Magnetic resonance imaging for disorders of liver vasculature

Topics in Magnetic Resonance Imaging

Volumn 13, Issue 3, 2002, Pages 177-190

  Morrin, Martina M ^a   Pedrosa, Ivan ^a   Rofsky, Neil M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cirrhosis; Gadolinum; Magnetic resonance angiography; Magnetic resonance imaging; Portal hypertension

Indexed keywords

DIAGNOSTIC IMAGING; EVALUATION; FLOW MEASUREMENT; HUMAN; LIVER ANGIOGRAPHY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

ADULT; AGED; CONTRAST MEDIA; FEMALE; GADOLINIUM; HEPATIC VEIN THROMBOSIS; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRCULATION; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; RADIOGRAPHIC IMAGE ENHANCEMENT; SENSITIVITY AND SPECIFICITY;

EID: 0036620732     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-200206000-00005     Document Type: Review

References (51)

1. Parker DL. Time of Flight Magnetic Resonance Angiography. New York: McGraw-Hill, 1995.
2. Unger EC, Cohen MS, Gatenby RA, et al. Single breath-holding scans of the abdomen using FISP and FLASH at 1.5 T. J Comput Assist Tomogr 1988;12:575-583.
3. Duerk JL, Lewin JS, Wendt M, et al. Remember true FISP? A high SNR, near 1-second imaging method for T2-like contrast in interventional MRI at .2 T. J Magn Reson Imaging 1998;8:203-208.
4. Prince MR. 3D Contrast Angiography. Berlin: Springer, 1997;3-28.
5. Prince MR, Chenevert TL, Foo TK, et al. Contrast-enhanced abdominal MR angiography: Optimization of imaging delay time by automating the detection of contrast material arrival in the aorta. Radiology 1997;203:109-114.
6. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212:876-884.
7. Earls JP, Rofsky NM, DeCorato DR, et al. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: Optimization with a test examination and a power injector. Radiology 1997;202:268-273.
8. Foo TK, Saranathan M, Prince MR, et al. Automated detection of bolus arrival and initiation of data acquisition in fast, three-dimensional, gadolinium-enhanced MR angiography. Radiology 1997;203:275-280.
9. Wilman AH, Riederer SJ, King BF, et al. Fluoroscopically triggered contrast-enhanced three-dimensional MR angiography with elliptical centric view order: Application to the renal arteries. Radiology 1997;205:137-146.
10. Edelman RR, Mattle HP, Kleefield J, et al. Quantification of blood flow with dynamic MR imaging and presaturation bolus tracking. Radiology 1989;171:551-556.
11. Edelman RR, Zhao B, Liu C, et al. MR angiography and dynamic flow evaluation of the portal venous system. AJR Am J Roentgenol 1989;153:755-760.
12. Misri H, Pockler-Schoniger C, Gaa J, et al. Ultrafast contrast-enhanced 3D MR angiography in the preoperative diagnosis of liver tumors. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1998;169:278-283.
13. Helmberger T, Semelka RC. New contrast agents for imaging the liver. Magn Reson Imaging Clin North Am 2001;9:745-766, vi.
14. Okumura A, Watanabe Y, Dohke M, et al. Contrast-enhanced three-dimensional MR portography. Radiographics 1999;19:973-987.
15. Popper H. Pathologic aspects of cirrhosis. A review. Am J Pathol 1977;87:228-264.
16. Groszmann RJ, Atterbury CE. The pathophysiology of portal hypertension: A basis for classification. Semin Liver Dis 1982;2:177-186.
17. Vosshenrich R, Fischer U. Contrast-enhanced MR angiography of abdominal vessels: Is there still a role for angiography? Eur Radiol 2002;12:218-230.
18. Vosshenrich R, Fischer U, Grabbe E. MR-angiography in portal hypertension. State of the art. Radiologe 2001;41:868-876.
19. Starzl TE, Francavilla A, Halgrimson CG, et al. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet 1973;137:179-199.
20. Ono N, Toyonaga A, Nishimura H, et al. Evaluation of magnetic resonance angiography on portosystemic collaterals in cirrhotic patients. Am J Gastroenterol 1997;92:1515-1519.
21. Muller MF, Siewert B, Stokes KR, et al. MR angiographic guidance for transjugular intrahepatic portosystemic shunt procedures. J Magn Reson Imaging 1994;4:145-150.
22. Williams DM, Cho KJ, Aisen AM, et al. Portal hypertension evaluated by MR imaging. Radiology 1985;157:703-706.
23. Saxena R, Adolph M, Ziegler JR, et al. Pylephlebitis: A case report and review of outcome in the antibiotic era. Am J Gastroenterol 1996;91:1251-1253.
24. Itai Y, Ohtomo K, Kokubo T, et al. Segmental intensity differences in the liver on MR images: A sign of intrahepatic portal flow stoppage. Radiology 1988;167:17-19.
25. McFarland EG, Kaufman JA, Saini S, et al. Preoperative staging of cancer of the pancreas: Value of MR angiography versus conventional angiography in detecting portal venous invasion. AJR Am J Roentgenol 1996;166:37-43.
26. Smedby O, Riesenfeld V, Karlson B, et al. Magnetic resonance angiography in the resectability assessment of suspected pancreatic tumors. Eur Radiol 1997;7:649-653.
27. Murphy FB, Steinberg HV, Shires GT 3rd, et al. The Budd-Chiari syndrome: A review. AJR Am J Roentgenol 1986;147:9-15.
28. Lassau N, Leclere J, Auperin A, et al. Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: Value of grayscale and Doppler US in 100 patients. Radiology 1997;204:545-552.
29. Hommeyer SC, Teefey SA, Jacobson AF, et al. Venoocclusive disease of the liver: Prospective study of US evaluation. Radiology 1992;184:683-686.
30. van den Bosch MA, van Hoe L. MR imaging findings in two patients with hepatic veno-occlusive disease following bone marrow transplantation. Eur Radiol 2000;10:1290-1293.
31. Mathieu D, Vasile N, Menu Y, et al. Budd-Chiari syndrome: Dynamic CT. Radiology 1987;165:409-413.
32. Kane R, Eustace S. Diagnosis of Budd-Chiari syndrome: Comparison between sonography and MR angiography. Radiology 1995;195:117-121.
33. Castellano G, Canga F, Solis-Herruzo JA, et al. Budd-Chiari syndrome associated with nodular regenerative hyperplasia of the liver. J Clin Gastroenterol 1989;11:698-702.
34. Lee VS, Lavelle MT, Krinsky GA, et al. Volumetric MR imaging of the liver and applications. Magn Reson Imaging Clin North Am 2001;9:697-716, v-vi.
35. Starzl TE, Marchmioro TL, Von Kaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynaecol Obstet 1963;117:659-676.
36. Freedman BJ, Lowe SC, Saouaf R. MR imaging in hepatic transplantation. Magn Reson Imaging Clin North Am 2001;9:821-839, vii.
37. Hughes LA, Hartnell GG, Finn JP, et al. Time-of-flight MR angiography of the portal venous system: Value compared with other imaging procedures. AJR Am J Roentgenol 1996;166:375-378.
38. Kopka L, Rodenwaldt J, Vosshenrich R, et al. Hepatic blood supply: Comparison of optimized dual phase contrast-enhanced three-dimensional MR angiography and digital subtraction angiography. Radiology 1999;211:51-58.
39. Lavelle MT, Lee VS, Rofsky NM, et al. Dynamic contrast-enhanced three-dimensional MR imaging of liver parenchyma: Source images and angiographic reconstructions to define hepatic arterial anatomy. Radiology 2001;218:389-394.
40. Lee VS, Lavelle MT, Rofsky NM, et al. Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: Feasibility, reproducibility, and technical quality. Radiology 2000;215:365-372.
41. Kreft B, Strunk H, Flacke S, et al. Detection of thrombosis in the portal venous system: Comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography. Radiology 2000;216:86-92.
42. Lomas DJ, Britton PD, Alexander GJ, et al. A comparison of MR and duplex Doppler ultrasound for vascular assessment prior to orthotopic liver transplantation. Clin Radiol 1994;49:307-310.
43. Naik KS, Ward J, Irving HC, et al. Comparison of dynamic contrast enhanced MRI and Doppler ultrasound in the preoperative assessment of the portal venous system. Br J Radiol 1997;70:43-49.
44. Nghiem HV, Winter TC 3rd, Mountford MC, et al. Evaluation of the portal venous system before liver transplantation: Value of phase-contrast MR angiography. AJR Am J Roentgenol 1995;164:871-878.
45. Langnas AN, Marujo W, Stratta RJ, et al. Vascular complications after orthotopic liver transplantation. Am J Surg 1991;161:76-82; discussion 82-83.
46. Pandharipande PV, Lee VS, Morgan GR, et al. Vascular and extravascular complications of liver transplantation: Comprehensive evaluation with three-dimensional contrast-enhanced volumetric MR imaging and MR cholangiopancreatography. AJR Am J Roentgenol 2001;177:1101-1107.
47. Stafford-Johnson DB, Hamilton BH, Dong Q, et al. Vascular complications of liver transplantation: Evaluation with gadolinium-enhanced MR angiography. Radiology 1998;207:153-160.
48. Finn JP, Edelman RR, Jenkins RL, et al. Liver transplantation: MR angiography with surgical validation. Radiology 1991;179:265-269.
49. Vignaux O, Legmann P, de Pinieux G, et al. Hemorrhagic necrosis due to peliosis hepatis: Imaging findings and pathological correlation. Eur Radiol 1999;9:454-456.
50. Gouya H, Vignaux O, Legmann P, et al. Peliosis hepatis: Triphasic helical CT and dynamic MRI findings. Abdom Imaging 2001;26:507-509.
51. Pliskin M. Peliosis hepatitis. Radiology 1975;114:29-30.